Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Current best practice in the management of neuroendocrine tumors.

Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G.

Ther Adv Endocrinol Metab. 2018 Oct 31;10:2042018818804698. doi: 10.1177/2042018818804698. eCollection 2019. Review.

2.

Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas.

Fazio N, Cinieri S, Lorizzo K, Squadroni M, Orlando L, Spada F, Maiello E, Bodei L, Paganelli G, Delle Fave G, de Braud F.

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S87-94. doi: 10.1016/S0305-7372(10)70026-8. Review.

PMID:
21129617
3.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
4.

Systemic treatment of neuroendocrine tumors with hepatic metastases.

Demirkan BH, Eriksson B.

Turk J Gastroenterol. 2012;23(5):427-37. Review.

5.

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants.

Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2. Review.

6.

Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.

Leung R, Lang B, Wong H, Chiu J, Yat WK, Shek T, Cho WY, Yau LC, Yau T.

Anticancer Agents Med Chem. 2013 Mar;13(3):382-8. Review.

PMID:
23092266
7.

Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.

Chan JA, Kulke MH.

Surg Oncol Clin N Am. 2016 Apr;25(2):423-37. doi: 10.1016/j.soc.2015.11.009. Epub 2016 Feb 19. Review.

PMID:
27013373
8.

Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.

Pasricha G, Padhi P, Daboul N, Monga DK.

Clin Ther. 2017 Nov;39(11):2146-2157. doi: 10.1016/j.clinthera.2017.10.010. Review.

PMID:
29173655
9.

Neuroendocrine pancreatic tumors: guidelines for management and update.

Burns WR, Edil BH.

Curr Treat Options Oncol. 2012 Mar;13(1):24-34. doi: 10.1007/s11864-011-0172-2. Review.

PMID:
22198808
10.

Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.

Cives M, Strosberg J.

Curr Treat Options Oncol. 2017 Mar;18(3):14. doi: 10.1007/s11864-017-0461-5. Review.

PMID:
28286921
11.

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.

Raj N, Reidy-Lagunes D.

Hematol Oncol Clin North Am. 2016 Feb;30(1):119-33. doi: 10.1016/j.hoc.2015.09.005. Epub 2015 Oct 23. Review.

12.

Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review.

Pusceddu S, De Braud F, Festinese F, Bregant C, Lorenzoni A, Maccauro M, Milione M, Concas L, Formisano B, Leuzzi L, Mazzaferro V, Buzzoni R.

Future Oncol. 2015;11(13):1947-59. doi: 10.2217/fon.15.86. Review.

PMID:
26161929
13.

Management of functional neuroendocrine tumors of the pancreas.

Öberg K.

Gland Surg. 2018 Feb;7(1):20-27. doi: 10.21037/gs.2017.10.08. Review.

14.

Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms.

Boutzios G, Kaltsas G.

Front Horm Res. 2015;44:40-57. doi: 10.1159/000382053. Epub 2015 Aug 14. Review.

PMID:
26303703
15.

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.

Alexandraki KI, Karapanagioti A, Karoumpalis I, Boutzios G, Kaltsas GA.

Biomed Res Int. 2017;2017:9856140. doi: 10.1155/2017/9856140. Epub 2017 Nov 19. Review.

16.

New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.

Phan AT, Kunz PL, Reidy-Lagunes DL.

Clin Adv Hematol Oncol. 2015 May;13(5 Suppl 5):1-18; quiz 1 p following 18.

PMID:
26430956
17.

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.

Chan HY, Grossman AB, Bukowski RM.

Adv Ther. 2010 Aug;27(8):495-511. doi: 10.1007/s12325-010-0045-2. Epub 2010 Jul 8. Review.

PMID:
20623346
18.

New treatment options for patients with advanced neuroendocrine tumors.

Chan JA, Kulke MH.

Curr Treat Options Oncol. 2011 Jun;12(2):136-48. doi: 10.1007/s11864-011-0148-2. Review.

PMID:
21437592
19.

Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.

Molina-Cerrillo J, Alonso-Gordoa T, Martínez-Sáez O, Grande E.

Oncologist. 2016 Jun;21(6):701-7. doi: 10.1634/theoncologist.2015-0455. Epub 2016 Apr 22. Review.

20.

Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment.

Díez M, Teulé A, Salazar R.

Ann Gastroenterol. 2013;26(1):29-36. Review.

Supplemental Content

Support Center